Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Women's Health

Women's Health: market research reports

Women's Health market research reports and industry analysis

Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others 8/1/2012 \| published by: BioSeeker Group AB ... competitive market. Locate the right drugs to benchmark against and see were others may have succeeded or failed before you. This report comprises defined and up to date development strategies for 470 breast cancer drugs ... \| read more...	$2,925.00
Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Colorectal Cancer and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Lung Cancer and Pancreatic Cancer 8/1/2012 \| published by: BioSeeker Group AB ... assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. Below is a short ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis 8/1/2012 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Chinese Markets for Breast Cancer Treatment Drugs 8/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors 8/1/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| read more...	$5,175.00
Emergency Contraception in the Netherlands 8/1/2012 \| published by: Euromonitor International ... level of unwanted pregnancies among the young population. Euromonitor International's Emergency Contraception in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest ... \| read more...	$900.00
Ureter Cancer – Pipeline Review, H2 2012 7/31/2012 \| published by: Global Markets Direct ... for Ureter Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ureter Cancer. 'Ureter Cancer - Pipeline Review, H2 2012' ... \| read more...	$500.00
Cervical Dysplasia Global Clinical Trials Review, H2, 2012 7/31/2012 \| published by: GlobalData ... and data relating to the clinical trials on Cervical Dysplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ... \| read more...	$2,500.00
Hormone Refractory Breast Cancer – Pipeline Review, H2 2012 7/31/2012 \| published by: Global Markets Direct ... provides information on the therapeutic development for Hormone Refractory Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hormone ... \| read more...	$500.00
Uterine Fibroids Global Clinical Trials Review, H2, 2012 7/24/2012 \| published by: GlobalData ... and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ... \| read more...	$2,500.00
Emergency Contraception in Austria 7/23/2012 \| published by: Euromonitor International ... attitudes towards sexuality in general as well as the rights of women. These positive attitudes had a rather positive impact on sales of emergency contraception products in Austria in 2011. The good performance of the ... \| read more...	$900.00
Global Breast Cancer Drugs Market 2011-2015 7/19/2012 \| published by: Infiniti Research Limited ... of breast cancer worldwide. The Global Breast Cancer Drugs market has also been witnessing the trend of the emergence of combination therapies to treat breast cancer effectively. However, the availability of alternative treatment methods could ... \| read more...	$1,500.00
Pregnancy Test Kit Manufacturing in the US - Industry Market Research Report 7/18/2012 \| published by: IBISWorld ... heightened unemployment and greater financial insecurity. Given that women who are planning pregnancy make up an estimated 60.0% of retail sales, this trend translated into lower downstream demand for pregnancy test kits manufactured by the ... \| read more...	$910.00
Fibromyalgia 7/16/2012 \| published by: Decision Resources ... from which fibromyalgia patients suffer. Heterogeneity in the fraction of patients who respond to a given therapy—and in the magnitude of that response—drives frequent treatment changes and additions. As a result, current treatment of this ... \| read more...	$15,000.00
The Indian Contraceptive Market Outlook to 2015 - ECP Overshadowing the Condoms Segment 7/1/2012 \| published by: Ken Research ... the basis of value and volume, market segmentation by free condom, social marketing condom and commercial marketing condom. The report also entails insight on government regulations on spreading awareness related to STD and distributing contraceptives. ... \| read more...	$525.00
Contraceptives - US - July 2012 7/1/2012 \| published by: Mintel International Group Ltd. ... that few manufacturers and retailers have been able to fully capitalize on growing demand for sexual health and wellness products that help protect against pregnancy and, in some cases, add to sexual pleasure. In order ... \| read more...	$3,995.00
Pregnancy Global Clinical Trials Review, H1, 2012 6/30/2012 \| published by: GlobalData ... relating to the clinical trials on Pregnancy/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a ... \| read more...	$2,500.00
Breast Cancer 6/13/2012 \| published by: Decision Resources ... cause of cancer-related death among women in the markets under study (United States, France, Germany, Italy, Spain, United Kingdom, and Japan). The treatment of distinct subpopulations of CaB is addressed by numerous agents including hormonal ... \| read more...	$15,000.00
Breast Cancer Diagnostic and Drug Technologies: Global Markets 6/1/2012 \| published by: BCC Research ... annual growth rate (CAGR) of 2.5% and reach $24 billion by 2016. The market for Breast cancer drugs reached $12.7 billion in 2010 and came down to $10.2 billion in 2011. The market is expected ... \| read more...	$5,450.00

< prev 1 2 3 4 5 6 7 8 9 10 next >